Showing results (151-160 of 377) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|December 6, 2017
Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptakeKosuke Kaji, Norihisa Nishimura, Kenichiro Seki, et al.
Hepatology (Baltimore, Md.)|March 27, 2002
Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinomaHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Journal of Gastroenterology|July 21, 2015
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitisTadashi Namisaki, Ryuichi Noguchi, Kei Moriya, et al.
International Journal of Oncology|April 6, 2005
In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinomaMisuzu Hitomi, Takako Nonomura, Fumi Yokoyama, et al.
International Journal of Molecular Sciences|June 6, 2019
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis ModelKeisuke Nakanishi, Kosuke Kaji, Mitsuteru Kitade, et al.
World Journal of Surgery|October 10, 2018
A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic CancerKota Nakamura, Masayuki Sho, Takahiro Akahori, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 5, 2011
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in ratsKosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade, et al.
International Journal of Oncology|December 22, 2007
Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularizationRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2010
Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in miceKosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade, et al.
International Journal of Molecular Sciences|July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated AngiogenesisNaoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Pageof 38